Identification of a Notch transcriptomic signature for breast cancer

被引:1
|
作者
Braune, Eike-Benjamin [1 ]
Geist, Felix [2 ]
Tang, Xiaojia [3 ]
Kalari, Krishna [3 ]
Boughey, Judy [4 ]
Wang, Liewei [5 ]
Leon-Ferre, Roberto A. [6 ]
D'Assoro, Antonino B. [6 ]
Ingle, James N. [6 ]
Goetz, Matthew P. [5 ,6 ]
Kreis, Julian [2 ]
Wang, Kang [7 ]
Foukakis, Theodoros [7 ]
Seshire, Anita [8 ]
Wienke, Dirk [2 ]
Lendahl, Urban [1 ]
机构
[1] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden
[2] Merck Healthcare KGaA, Darmstadt, Germany
[3] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA
[4] Mayo Clin, Dept Surg, Rochester, MN USA
[5] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA
[6] Mayo Clin, Dept Oncol, Rochester, MN USA
[7] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[8] Merck KGaA, Darmstadt, Germany
关键词
Breast cancer; Basal-like; Breast cancer stem cell; Notch signalling; Transcriptomic signature; Therapy; Therapy resistance; Triple-negative; Diagnostics; GENE-EXPRESSION SIGNATURE; TUMOR-INITIATING CELLS; SIGNALING PATHWAY; ESTROGEN-RECEPTOR; C-MYC; MAMMARY; DIFFERENTIATION; PROMOTES; TARGET; GROWTH;
D O I
10.1186/s13058-023-01757-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundDysregulated Notch signalling contributes to breast cancer development and progression, but validated tools to measure the level of Notch signalling in breast cancer subtypes and in response to systemic therapy are largely lacking. A transcriptomic signature of Notch signalling would be warranted, for example to monitor the effects of future Notch-targeting therapies and to learn whether altered Notch signalling is an off-target effect of current breast cancer therapies. In this report, we have established such a classifier.MethodsTo generate the signature, we first identified Notch-regulated genes from six basal-like breast cancer cell lines subjected to elevated or reduced Notch signalling by culturing on immobilized Notch ligand Jagged1 or blockade of Notch by gamma-secretase inhibitors, respectively. From this cadre of Notch-regulated genes, we developed candidate transcriptomic signatures that were trained on a breast cancer patient dataset (the TCGA-BRCA cohort) and a broader breast cancer cell line cohort and sought to validate in independent datasets.ResultsAn optimal 20-gene transcriptomic signature was selected. We validated the signature on two independent patient datasets (METABRIC and Oslo2), and it showed an improved coherence score and tumour specificity compared with previously published signatures. Furthermore, the signature score was particularly high for basal-like breast cancer, indicating an enhanced level of Notch signalling in this subtype. The signature score was increased after neoadjuvant treatment in the PROMIX and BEAUTY patient cohorts, and a lower signature score generally correlated with better clinical outcome.ConclusionsThe 20-gene transcriptional signature will be a valuable tool to evaluate the response of future Notch-targeting therapies for breast cancer, to learn about potential effects on Notch signalling from conventional breast cancer therapies and to better stratify patients for therapy considerations.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Identification of an immune-related gene pair signature in breast cancer
    Zhan, Yue
    Guan, Xin
    Zhang, Yu
    Zhu, Zhenhua
    Shi, Aiping
    Fan, Zhimin
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, 11 (06) : 1523 - +
  • [32] Identification of a circulating MicroRNA signature to distinguish recurrence in breast cancer patients
    Huo, Dezheng
    Clayton, Wendy M.
    Yoshimatsu, Toshio F.
    Chen, Jianjun
    Olopade, Olufunmilayo I.
    [J]. ONCOTARGET, 2016, 7 (34) : 55231 - 55248
  • [33] Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival
    Fan, Chunni
    Du, Jianshi
    Liu, Ning
    [J]. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2021, 2021
  • [34] Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
    Xing, Ai-Yan
    Wang, Bin
    Li, Yu-Hong
    Chen, Xu
    Wang, Ya-Wen
    Liu, Hai-Ting
    Gao, Peng
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [35] Identification of a novel ubiquitination related gene signature for patients with breast cancer
    Zheng, Yuan
    Lu, Wenliang
    Chen, Bo
    Zhao, Kankan
    [J]. MEDICINE, 2022, 101 (37) : E30598
  • [36] Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer
    Foulds, Gemma A.
    Vadakekolathu, Jayakumar
    Abdel-Fatah, Tarek M. A.
    Nagarajan, Divya
    Reeder, Stephen
    Johnson, Catherine
    Hood, Simon
    Moseley, Paul M.
    Chan, Stephen Y. T.
    Pockley, A. Graham
    Rutella, Sergio
    McArdle, Stephanie E. B.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [37] Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients
    A. W. Mao
    H. Barck
    J. Young
    A. Paley
    J. -H. Mao
    H. Chang
    [J]. Clinical and Translational Oncology, 2022, 24 : 597 - 604
  • [38] Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients
    Mao, A. W.
    Barck, H.
    Young, J.
    Paley, A.
    Mao, J-H
    Chang, H.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (03): : 597 - 604
  • [39] Identification of Epac1 transcriptomic signature in ventricular myocytes
    Detrait, Maximin
    Agbegbo, Ezechiel
    Formoso, Karina
    Lezoualc'h, Frank
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 173 : S164 - S164
  • [40] A host transcriptomic signature for identification of respiratory viral infections in the community
    Almansa, Raquel
    Herrero-Rodriguez, Carmen
    Martinez-Huelamo, Misericordia
    Vicente-Andres, Maria del Pilar
    Nieto-Barbero, Jose Angel
    Martin-Ballesteros, Miryam
    Rodilla-Carvajal, Maria del Mar
    de la Fuente, Amanda
    Ortega, Alicia
    Alonso-Ramos, Maria Jesus
    Wacker, James
    Liesenfeld, Oliver
    Sweeney, Timothy E.
    Bermejo-Martin, Jesus F.
    Garcia-Ortiz, Luis
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (12)